The study utilized a prevalence-based cost of illness framework that incorporated data from publicly available databases, published literature and a consensus panel of expert physicians.
Against this background, the present study utilized a prevalence-based cost-of-illness framework to estimate the annual cost of illness of hyponatremia in the U.S. The analysis incorporates data from publicly available databases, published literature, and an expert physician panel.
Newly initiated studies utilizing Ad based HIV vaccines in Ad-naive vaccinees should help clarify these issues.
In the first normalization step, we utilized a LOWESS algorithm based on all the probes of the array.
The sub-analyses utilized a baseline sample based on the selection criteria described above.
This study utilized a qualitative approach based on narratives written by the adolescents.
This study utilized a qualitative design based on semi-structured, one-to-one interviews.
Pharmacokinetic analysis of data utilized an Excel based add-on developed at Allergan, Inc. (Irvine, CA).
Threshold for significant cross-correlation was calculated utilizing a method based on surrogate time series.
The review criteria utilizes a number (based on study design) and A, B, or C (high, good, low study quality).
Stratifying the prevalence based on age revealed a prevalence of 6.6%, 17.7%, and 18.3% for ages 20 39, 40 59, 60 years and older, respectively, by NCEP criteria.
